Potential role of CYLD (Cylindromatosis) as a deubiquitinating enzyme in vascular cells

American Journal of Pathology

Volumn 172, Issue 3, 2008, Pages 818-829

  Takami, Yoichi ^a   Nakagami, Hironori ^a   Morishita, Ryuichi ^a   Katsuya, Tomohiro ^a   Hayashi, Hiroki ^a   Mori, Masaki ^a   Koriyama, Hiroshi ^a   Baba, Yoshichika ^a   Yasuda, Osamu ^a   Rakugi, Hiromi ^a   Ogihara, Toshio ^a   Kaneda, Yasufumi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYLD PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN; PROTEIN BCL 3; TRANSCRIPTION FACTOR E2F; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CATALYSIS; CELL CULTURE; CELL NUCLEUS; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYLINDROMA; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTIMA; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SMOOTH MUSCLE FIBER; UBIQUITINATION; UPREGULATION; VASCULAR SMOOTH MUSCLE;

EID: 40449085241     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070312     Document Type: Article

References (35)

1. K Haglund I Dikic Ubiquitylation and cell signaling EMBO J 24 2005 3353 3359
2. GH Gibbons VJ Dzau Molecular therapies for vascular diseases Science 272 1996 689 693
3. A D'Andrea D Pellman Deubiquitinating enzymes: a new class of biological regulators Crit Rev Biochem Mol Biol 33 1998 337 352
4. S Meiners M Laule W Rother C Guenther I Prauka P Muschick G Baumann PM Kloetzel K Stangl Ubiquitin-proteasome pathway as a new target for the prevention of restenosis Circulation 105 2002 483 489
5. GR Bignell W Warren S Seal M Takahashi E Rapley R Barfoot H Green C Brown PJ Biggs SR Lakhani C Jones J Hansen E Blair B Hofmann R Siebert G Turner DG Evans C Schrander-Stumpel FA Beemer A van Den Ouweland D Halley B Delpech MG Cleveland I Leigh J Leisti S Rasmussen Identification of the familial cylindromatosis tumour-suppressor gene Nat Genet 25 2000 160 165
6. S Yoshimura R Morishita K Hayashi K Yamamoto H Nakagami Y Kaneda N Sakai T Ogihara Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element ‘decoy’ of nuclear factor-kappaB binding site as a novel molecular strategy Gene Ther 8 2001 1635 1642
7. H Nakagami R Morishita K Yamamoto Y Taniyama M Aoki K Matsumoto T Nakamura Y Kaneda M Horiuchi T Ogihara Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK. STAT3, and AKT in endothelial cells Hypertension 37 2001 581 586
8. H Matsushita R Morishita T Nata M Aoki H Nakagami Y Taniyama K Yamamoto J Higaki K Yasufumi T Ogihara Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation Circ Res 86 2000 974 981
9. R Massoumi K Chmielarska K Hennecke A Pfeifer R Fassler Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling Cell 125 2006 665 677
10. H Niwa K Yamamura J Miyazaki Efficient selection for high-expression transfectants with a novel eukaryotic vector Gene 108 1991 193 199
11. H Nakagami M Takemoto JK Liao NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy J Mol Cell Cardiol 35 2003 851 859
12. R Morishita GH Gibbons KE Ellison M Nakajima L Zhang Y Kaneda T Ogihara VJ Dzau Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia Proc Natl Acad Sci USA 90 1993 8474 8478
13. X Yin C Yutani Y Ikeda K Enjyoji H Ishibashi-Ueda S Yasuda Y Tsukamoto H Nonogi Y Kaneda H Kato Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries Cardiovasc Res 56 2002 454 463
14. N Ouchi S Kihara Y Arita K Maeda H Kuriyama Y Okamoto K Hotta M Nishida M Takahashi T Nakamura S Yamashita T Funahashi Y Matsuzawa Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin Circulation 100 1999 2473 2476
15. ZJ Chen Ubiquitin signalling in the NF-kappaB pathway Nat Cell Biol 7 2005 758 765
16. L Deng C Wang E Spencer L Yang A Braun J You C Slaughter C Pickart ZJ Chen Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain Cell 103 2000 351 361
17. A Kovalenko C Chable-Bessia G Cantarella A Israel D Wallach G Courtois The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination Nature 424 2003 801 805
18. J Zhang B Stirling ST Temmerman CA Ma IJ Fuss JM Derry A Jain Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice J Clin Invest 116 2006 3042 3049
19. TR Brummelkamp SM Nijman AM Dirac R Bernards Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB Nature 424 2003 797 801
20. E Trompouki E Hatzivassiliou T Tsichritzis H Farmer A Ashworth G Mosialos CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members Nature 424 2003 793 796
21. NJ Thornburg R Pathmanathan N Raab-Traub Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma Cancer Res 63 2003 8293 8301
22. PC Cogswell DC Guttridge WK Funkhouser AS Baldwin Jr Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3 Oncogene 19 2000 1123 1131
23. IV Budunova P Perez VR Vaden VS Spiegelman TJ Slaga JL Jorcano Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis Oncogene 18 1999 7423 7431
24. H Jono JH Lim LF Chen H Xu E Trompouki ZK Pan G Mosialos JD Li NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway J Biol Chem 279 2004 36171 36174
25. W Reiley M Zhang X Wu E Granger SC Sun Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation Mol Cell Biol 25 2005 3886 3895
26. C Schmidt B Peng Z Li GM Sclabas S Fujioka J Niu M Schmidt-Supprian DB Evans JL Abbruzzese PJ Chiao Mechanisms of proinflammatory cytokine-induced biphasic NF-kappaB activation Mol Cell 12 2003 1287 1300
27. ZJ Chen L Parent T Maniatis Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity Cell 84 1996 853 862
28. L Chen W Fischle E Verdin WC Greene Duration of nuclear NF-kappaB action regulated by reversible acetylation Science 293 2001 1653 1657
29. R Marfella M D'Amico C Di Filippo A Baldi M Siniscalchi FC Sasso M Portoghese O Carbonara B Crescenzi P Sangiuolo GF Nicoletti R Rossiello F Ferraraccio F Cacciapuoti M Verza L Coppola F Rossi G Paolisso Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment J Am Coll Cardiol 47 2006 2444 2455
30. R Marfella M D'Amico K Esposito A Baldi C Di Filippo M Siniscalchi FC Sasso M Portoghese F Cirillo F Cacciapuoti O Carbonara B Crescenzi F Baldi A Ceriello GF Nicoletti F D'Andrea M Verza L Coppola F Rossi D Giugliano The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment Diabetes 55 2006 622 632
31. M Rodriguez-Porcel LO Lerman DR Holmes Jr D Richardson C Napoli A Lerman Chronic antioxidant supplementation attenuates nuclear factor-kappa B activation and preserves endothelial function in hypercholesterolemic pigs Cardiovasc Res 53 2002 1010 1018
32. J Herrmann WD Edwards DR Holmes Jr KL Shogren LO Lerman A Ciechanover A Lerman Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes J Am Coll Cardiol 40 2002 1919 1927
33. J Thyberg K Blomgren Effects of proteasome and calpain inhibitors on the structural reorganization and proliferation of vascular smooth muscle cells in primary culture Lab Invest 79 1999 1077 1088
34. P Dikshit M Chatterjee A Goswami A Mishra NR Jana Aspirin induces apoptosis through the inhibition of proteasome function J Biol Chem 281 2006 29228 29235
35. C Wójcik M Bury T Stoklosa A Giermasz W Feleszko I Mlynarczuk E Pleban G Basak S Omura M Jakobisiak Lovastatin and simvastatin are modulators of the proteasome Int J Biochem Cell Biol 32 2000 957 965